Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 24
2003 19
2004 11
2005 23
2006 23
2007 14
2008 17
2009 16
2010 14
2011 16
2012 11
2013 14
2014 11
2015 13
2016 13
2017 17
2018 9
2019 8
2020 21
2021 19
2022 22
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Microscopic computed tomography with AI-CNN powered image analysis: the path to phenotype the bleomycin-induced pulmonary injury.
Henneke I, Pilz C, Wilhelm J, Alexopoulos I, Ezaddoustdar A, Mukhametshina R, Weissmann N, Ghofrani HA, Grimminger F, Seeger W, Schermuly RT, Wygrecka M, Kojonazarov B. Henneke I, et al. Among authors: grimminger f. Am J Physiol Cell Physiol. 2024 Apr 22. doi: 10.1152/ajpcell.00708.2023. Online ahead of print. Am J Physiol Cell Physiol. 2024. PMID: 38646782
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis.
Yogeswaran A, Gall H, Fünderich M, Wilkins MR, Howard L, Kiely DG, Lawrie A, Hassoun PM, Sirenklo Y, Torbas O, Sweatt AJ, Zamanian RT, Williams PG, Frauendorf M, Arvanitaki A, Giannakoulas G, Saleh K, Sabbour H, Cajigas HR, Frantz R, Al Ghouleh I, Chan SY, Brittain E, Annis JS, Pepe A, Ghio S, Orfanos S, Anthi A, Majeed RW, Wilhelm J, Ghofrani HA, Richter MJ, Grimminger F, Sahay S, Tello K, Seeger W; Pulmonary Vascular Research Institute GoDeep Consortium. Yogeswaran A, et al. Among authors: grimminger f. Chest. 2024 Mar 19:S0012-3692(24)00309-X. doi: 10.1016/j.chest.2024.03.018. Online ahead of print. Chest. 2024. PMID: 38508334 Free article.
miR-147b mediated suppression of DUSP8 promotes lung cancer progression.
Turkowski K, Herzberg F, Günther S, Weigert A, Haselbauer T, Fink L, Brunn D, Grimminger F, Seeger W, Sültmann H, Stiewe T, Pullamsetti SS, Savai R. Turkowski K, et al. Among authors: grimminger f. Oncogene. 2024 Apr;43(16):1178-1189. doi: 10.1038/s41388-024-02969-7. Epub 2024 Feb 23. Oncogene. 2024. PMID: 38396293 Free PMC article.
Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice.
Hadzic S, Wu CY, Gredic M, Pak O, Loku E, Kraut S, Kojonazarov B, Wilhelm J, Brosien M, Bednorz M, Seimetz M, Günther A, Kosanovic D, Sommer N, Warburton D, Li X, Grimminger F, Ghofrani HA, Schermuly RT, Seeger W, El Agha E, Bellusci S, Weissmann N. Hadzic S, et al. Among authors: grimminger f. Eur Respir J. 2023 Nov 9;62(5):2201606. doi: 10.1183/13993003.01606-2022. Print 2023 Nov. Eur Respir J. 2023. PMID: 37884305 Free PMC article.
The Early Detection of Pulmonary Hypertension.
Ley L, Grimminger F, Richter M, Tello K, Ghofrani A, Bandorski D. Ley L, et al. Among authors: grimminger f. Dtsch Arztebl Int. 2023 Dec 1;120(48):823-830. doi: 10.3238/arztebl.m2023.0222. Dtsch Arztebl Int. 2023. PMID: 37882345 Free PMC article. Review.
Case Report: Durable therapy response to Osimertinib in rare EGFR Exon 18 mutated NSCLC.
Cekay M, Arndt PF, Dumitrascu R, Savai R, Braeuninger A, Gattenloehner S, Steiner D, Roller F, Tello K, Hattar K, Seeger W, Sibelius U, Grimminger F, Eul B. Cekay M, et al. Among authors: grimminger f. Front Oncol. 2023 Aug 16;13:1182391. doi: 10.3389/fonc.2023.1182391. eCollection 2023. Front Oncol. 2023. PMID: 37655099 Free PMC article.
Hepatorenal dysfunction in patients with chronic thromboembolic pulmonary hypertension.
Yogeswaran A, Zedler D, Richter MJ, Steinke S, Rako ZA, Kremer NC, Grimminger F, Seeger W, Ghofrani HA, Gall H, Tello K. Yogeswaran A, et al. Among authors: grimminger f. Front Med (Lausanne). 2023 Jul 20;10:1207474. doi: 10.3389/fmed.2023.1207474. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37547612 Free PMC article.
ADPGK-AS1 long noncoding RNA switches macrophage metabolic and phenotypic state to promote lung cancer growth.
Karger A, Mansouri S, Leisegang MS, Weigert A, Günther S, Kuenne C, Wittig I, Zukunft S, Klatt S, Aliraj B, Klotz LV, Winter H, Mahavadi P, Fleming I, Ruppert C, Witte B, Alkoudmani I, Gattenlöhner S, Grimminger F, Seeger W, Pullamsetti SS, Savai R. Karger A, et al. Among authors: grimminger f. EMBO J. 2023 Sep 18;42(18):e111620. doi: 10.15252/embj.2022111620. Epub 2023 Aug 7. EMBO J. 2023. PMID: 37545364 Free PMC article.
314 results